Bifidobacterium adolescentis protects against necrotizing enterocolitis and upregulates TOLLIP and SIGIRR in premature neonatal rats
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bifidobacterium adolescentis protects against necrotizing enterocolitis and upregulates TOLLIP and SIGIRR in premature neonatal rats ; volume:17 ; number:1 ; day:5 ; month:1 ; year:2017 ; pages:1-7 ; date:12.2017
BMC pediatrics ; 17, Heft 1 (5.1.2017), 1-7, 12.2017
- Urheber
-
Wu, Wenshen
- Beteiligte Personen und Organisationen
-
Wang, Yanli
Zou, Jingjing
Long, Fang
Yan, Huiheng
Zeng, Lijuan
Chen, Yunbin
SpringerLink (Online service)
- DOI
-
10.1186/s12887-016-0759-7
- URN
-
urn:nbn:de:1111-201702216674
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wu, Wenshen
- Wang, Yanli
- Zou, Jingjing
- Long, Fang
- Yan, Huiheng
- Zeng, Lijuan
- Chen, Yunbin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advanced Necrotizing Enterocolitis Part 1: Mortality
Nomogram for predicting fulminant necrotizing enterocolitis
Neonatal intestinal dysbiosis in necrotizing enterocolitis
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Prevention Strategies and Management of Necrotizing Enterocolitis
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
An anti-eCIRP strategy for necrotizing enterocolitis
Translating regenerative medicine therapies in neonatal necrotizing enterocolitis
International Survey on the Management of Necrotizing Enterocolitis
Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies
Necrotizing enterocolitis: current understanding of the prevention and management
Advanced Necrotizing Enterocolitis Part 1: Mortality
Nomogram for predicting fulminant necrotizing enterocolitis
Neonatal intestinal dysbiosis in necrotizing enterocolitis
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Prevention Strategies and Management of Necrotizing Enterocolitis
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
An anti-eCIRP strategy for necrotizing enterocolitis
Translating regenerative medicine therapies in neonatal necrotizing enterocolitis
International Survey on the Management of Necrotizing Enterocolitis
Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies
Necrotizing enterocolitis: current understanding of the prevention and management
Advanced Necrotizing Enterocolitis Part 1: Mortality
Nomogram for predicting fulminant necrotizing enterocolitis
Neonatal intestinal dysbiosis in necrotizing enterocolitis
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Prevention Strategies and Management of Necrotizing Enterocolitis
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
An anti-eCIRP strategy for necrotizing enterocolitis
Translating regenerative medicine therapies in neonatal necrotizing enterocolitis
International Survey on the Management of Necrotizing Enterocolitis
Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies